Press Releases
Filters
July 28, 2021
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
July 8, 2021
Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
June 23, 2021
Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
May 25, 2021
Viatris Inc. to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
May 10, 2021
Viatris Inc. Reports Strong First Quarter 2021 Financial Results, Reaffirms 2021 Guidance and Announces Inaugural Quarterly Dividend
May 6, 2021
Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities Worldwide
Displaying 161 - 170 of 185